Chief Medical Officer, Dr. Alka Chaubey, presented at The Festival of Genomics & Biodata evidence supporting her vision of Optical Genome Mapping (OGM) with #Saphyr as a first line test in genetic disease and cancer. https://t.co/Z33YC2eYhF #Bionano